|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-7-23
|
|
pubmed:abstractText |
Profound hearing loss is a serious complication of neurofibromatosis type 2, a genetic condition associated with bilateral vestibular schwannomas, benign tumors that arise from the eighth cranial nerve. There is no medical treatment for such tumors.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropilin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropilin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
2009 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
23
|
|
pubmed:volume |
361
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
358-67
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19587327-Adolescent,
pubmed-meshheading:19587327-Adult,
pubmed-meshheading:19587327-Angiogenesis Inhibitors,
pubmed-meshheading:19587327-Antibodies, Monoclonal,
pubmed-meshheading:19587327-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:19587327-Female,
pubmed-meshheading:19587327-Hearing Loss,
pubmed-meshheading:19587327-Humans,
pubmed-meshheading:19587327-Male,
pubmed-meshheading:19587327-Middle Aged,
pubmed-meshheading:19587327-Neurofibromatosis 2,
pubmed-meshheading:19587327-Neuroma, Acoustic,
pubmed-meshheading:19587327-Neuropilin-1,
pubmed-meshheading:19587327-Neuropilin-2,
pubmed-meshheading:19587327-Retrospective Studies,
pubmed-meshheading:19587327-Vascular Endothelial Growth Factor A,
pubmed-meshheading:19587327-Vascular Endothelial Growth Factor Receptor-2,
pubmed-meshheading:19587327-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.
|
|
pubmed:affiliation |
Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. splotkin@partners.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
